BRUSSELS, Jan. 29 (Xinhua) -- The COVID-19 vaccine developed by AstraZeneca and Oxford University was authorized for use by the European Medicines Agency (EMA), the drug regulator of the European Union (EU), on Friday.
The EMA said it had assessed the safety and effectiveness of the vaccine and recommended that a formal conditional marketing authorization be granted by the European Commission, the executive arm of the EU.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!